Summary
Increased sialic acid levels reflecting tumor burden are found on the surface of T-lymphocytes and in the plasma of patients with carcinoma of the mammary gland. The data of the determinations of sialic acid content and distribution on T-cells, using microanalytical methods such as HPLC and a colorimetric test, show that the total sialic acid content is increased by about 60% and that nearly 80–90% of the sialic acids consist of Nacetyl-9-O-acetyl-neuraminic acid, in comparison to the healthy controls (not containing O-acetylated neuraminic acid). Investigations on lymphocytes of malignant melanoma patients show similar changes of sialic acid content and distribution on the cell surface.
Increased sialic acid levels are also found in the plasma of patients with cancer but no O-acetylated derivative can be found.
Furthermore the examinations show that the separation of the T-lymphocytes from the total lymphocyte fraction is not required. Determination of sialic acids in the total lymphocyte fraction can be a simplification in carrying out further diagnostic investigations.
A high level of sialic acids as “antirecognition factor” seems to be not only a marker of tumor cells but also an attribute of T-lymphocytes, involved in the defence against the malignoma (malignant melanoma, breast cancer).
Considering the possible contribution of sialic acid to the immunoregulatory protective mechanism during the first stage of pregnancy, sialic acid content and distribution on T-cells of pregnant women are investigated. Both an increase and a change in the distribution of sialic acids can be excluded.
Similar content being viewed by others
Abbreviations
- HPLC:
-
High performance liquid chromatography
- Neu 5 Ac:
-
N-Acetyl-neuraminsäure
- Neu 5, 9 Ac2 :
-
N-Acetyl-9-O-acetyl-neuraminsäure
Literatur
Alhadeff JA, Holzinger RT (1982) Sialyltransferase, sialic acid and sialoglycoconjugates in metastatic tumor und human liver tissue. Int J Biochem 14:119
Boyum A (1968) Isolation of leucocytes from human blood; further observations. Scand J Clin Lab Invest 21, Suppl 97:31
Corfield AP, Sander-Wewer M, Veh RW, Wember M, Schauer R (1986) The action of sialidases on substrates containing O-acetylsialic acids. Biol Chem Hoppe-Seyler 367:433
Eide TJ, Nielsen K, Solberg S (1987) Dysplasia in colorectal adenomas related to the presence of O-acylated sialic mucin and to morphometric measurements. Acta Path Microbiol Immunol Scand Sect A 95:365
Henn KH, Gressner AM (1987) Zur klinischen Wertigkeit der Sialinsäure im Serum bei benignen und malignen Erkrankungen. J Clin Chem Clin Biochem 25:423
Hogan-Ryan A, Fennelly JJ (1981) Serum sialic acid concentrations in malignant melanoma. Eur J Cancer Clin Oncol 17:843
Holzhauser R, Faillard H, Klose W, Huber W, Stickl H, Landthaler M (1988) Alterations of acyl-neuraminic acids on T-lymphocytes in cases of melanoma. Klin Wochenschr 66:540
Holzhauser R, Faillard H (1988) Sialic acids in human lymphocytes. Qualitative and quantitative alterations in cancer cases. Carbohydr Res 183:89
Julius MH, Simpson E, Herzberg LA (1973) A rapid method for the isolation of functional thymus-murine lymphocytes. Eur J Immunol 3:645
Kamerling J, Makovitzky J, Schauer R, Vliegenthart JFG, Wember M (1982) The nature of sialic acids in human lymphocytes. Biochim Biophys Acta 714:351
Merishi JN, Zeiller K (1974) T- and B-lymphocytes: striking differences in surface membranes. Brit Med J 1:360
O'Kennedy R, Smyth H, Corrigan A, Clynes M (1982) Total and surface-located sialic acid levels in normal and leukaemic lymphocytes: relationship to T and B cell nature and to location in vivo. Eur J Cancer Clin Oncol 18:437
Schauer R (1978) Characterization of sialic acids. Meth Enzymol 50 C:64
Schauer R (1982) Chemistry, metabolism, and biological functions of sialic acids. Adv Carbohydr Chem Biochem 40:131
Schauer R (1985) Sialic acids and their role as biological masks. TIBS 10:357
Schauer R (1987) Sialic acids: metabolism of O-acetyl-groups. Meth Enzymol 138:611
Schauer R, Reuter G, Stoll S (1988) Sialate O-acetylesterases: key enzymes in sialic acid catabolism. Biochimie 70:1511
Shamberger RJ (1984) Serum sialic acid in normals and in cancer patients. J Clin Chem Clin Biochem 22:647
Shukla AK, Stoll S, Schauer R (1984) Substrate specificity of two sialate O-acetylesterases from equine liver. Biol Chem Hoppe-Seyler 365:1065
Silver HKB, Karim KA, Archibald EL, Salinas FA (1979) Serum sialic and sialyltransferase as monitors of tumor burden in malignant melanoma patients. Cancer Res 39:5036
Silver HKB, Rangel DM, Morton DL (1978) Serum sialic acid elevations in malignant melanoma patients. Cancer 41:1497
Skoza L, Mohos St (1976) Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Biochem J 159:457
Stefenelli N, Klotz H, Engel A, Bauer P (1985) Serum sialic acids in malignant tumors, bacterial infections, and chronic liver diseases. J Cancer Res Clin Oncol 109:55
Yogeeswaran G, Salk PL (1981) Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 212:1514
Author information
Authors and Affiliations
Additional information
Diese Arbeit wurde unterstützt von der Deutschen Forschungsgemeinschaft (Fa 45/4).
Rights and permissions
About this article
Cite this article
Stickl, H., Huber, W., Faillard, H. et al. Veränderung der Acylneuraminsäuregehalte auf T-Lymphozyten und im Plasma bei Erkrankung an Mamma-Karzinom. Klin Wochenschr 69, 5–9 (1991). https://doi.org/10.1007/BF01649046
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01649046